Surmodics Inc
Company Profile
Business description
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Contact
9924 West 74th Street
Eden PrairieMN55344
USAT: +1 952 500-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
389
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,626.20 | 52.80 | 0.62% |
| CAC 40 | 7,942.42 | 58.79 | 0.75% |
| DAX 40 | 24,036.11 | 101.13 | 0.42% |
| Dow JONES (US) | 42,677.24 | 114.83 | -0.27% |
| FTSE 100 | 8,781.12 | 81.81 | 0.94% |
| HKSE | 23,792.11 | 110.63 | 0.47% |
| NASDAQ | 19,142.71 | 72.75 | -0.38% |
| Nikkei 225 | 37,454.14 | 75.35 | -0.20% |
| NZX 50 Index | 12,699.61 | 55.38 | 0.44% |
| S&P 500 | 5,940.46 | 23.14 | -0.39% |
| S&P/ASX 200 | 8,401.90 | 58.60 | 0.70% |
| SSE Composite Index | 3,393.49 | 13.02 | 0.39% |